Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Pulmonary Drug Delivery Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026

Report Description

Global Pulmonary Drug Delivery Devices Market: Overview

The pulmonary route of administration has proven to be effective in local and systemic delivery of miscellaneous drugs and biopharmaceuticals to treat pulmonary and non-pulmonary diseases. Inhalation therapy is the best option to treat to treat lung diseases such as asthma and cystic fibrosis. The global pulmonary drug delivery devices market is expanding at a significant pace due to factors such as increase in incidence of lung diseases and rise in digitalization of inhaler devices, which offers convenience to patients.

The global pulmonary drug delivery devices market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, application, distribution channel, and region. A detailed qualitative analysis of drivers, restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises competitive matrix and company profiles to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by geography and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global pulmonary drug delivery devices market.

Global Pulmonary Drug Delivery Devices Market: Key Segments

In terms of product, the global pulmonary drug delivery devices market has been segmented into dry powder inhalers, metered dose inhalers, and nebulizers. The dry powder inhalers segment has been further sub-segmented into single dose inhalers, and multi-dose inhalers. The metered dose inhalers segment has been further split into total manually-actuated pressurized inhaler and breath-actuated pressurized inhaler. The nebulizers segment has been further sub-segmented into jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. The product segment has been analyzed based on different type of devices uses to treat different pulmonary diseases in various regions. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. In terms of application, the global pulmonary drug delivery devices market has been segregated into asthma, COPD, cystic fibrosis, and others. In term of end-user, the global pulmonary drug delivery devices market has been classified into retail pharmacies, hospital pharmacies, and e-commerce. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the period from 2018 to 2026, considering 2017 as the base year.

Global Pulmonary Drug Delivery Devices Market: Regional Outlook

The global pulmonary drug delivery devices market has been segmented into five major regions and key countries/sub-regions in the respective region are: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, Israel, and Rest of MEA). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the period from 2018 to 2026, considering 2017 as the base year. The research study also provides the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the market in terms of various attributes such as company overview, financial overview, devices portfolios, business strategies, and recent developments. Major companies profiled in the global pulmonary drug delivery devices market include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca plc, Koninklijke Philips N.V., 3M Healthcare, Omron Corporation, F. Hoffmann-La Roche Ltd., Novartis AG, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., MannKind Corporation, Mylan N.V., Sunovion Pharmaceuticals, Inc., PARI GmbH, and Nypro Healthcare Inc. (Jabil Circuit Inc.) The global pulmonary drug delivery devices market has been segmented as follows:

Global Pulmonary Drug Delivery Devices Market, by Product

  • Dry Powder Inhalers
    • Single Dose Inhalers
    • Multi-dose Inhalers
  • Metered Dose Inhalers
    • Manually-actuated Pressurized Inhaler
    • Breath-actuated Pressurized Inhaler
  • Nebulizers
    • Jet Nebulizers
    • Ultrasonic Wave Nebulizers
    • Vibrating Mesh Nebulizers

Global Pulmonary Drug Delivery Devices Market, by Application

  • Asthma
  • COPD
  • Cystic Fibrosis
  • Others

Global Pulmonary Drug Delivery Devices Market, by Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • E-commerce

Global Pulmonary Drug Delivery Devices Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote